Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-29 @ 5:08 PM
Study NCT ID:
NCT00524303
Status:
COMPLETED
Last Update Posted:
2016-11-11
First Post:
2007-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-31
First Submit QC Date:
None
Study First Post Date:
2007-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-07-14
Results First Submit QC Date:
None
Results First Post Date:
2011-08-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-23
Last Update Post Date:
2016-11-11
Last Update Post Date Type:
ESTIMATED